Our findings from cell line data analysis are consistent with an earlier report of Martin-Trujillo et al. [14] who observed frequent amplifications and rare deletions of GNAS, BLCAP, L3MBTL1, and MSCT2 (PSIMCT-1) in lung, colorectal, breast, and hepatocellular carcinoma primary tumors from the Cancer Genome Atlas (TCGA), including a range of copy number gains and losses of all four genes in lung cancer tumors. This evidence concerns the gene BLCAP and hepatocellular carcinoma.